Table 1.
Tissue Origins and Number of Cylinder Analyzed for the Specific Antigens
| Malignant Tissues |
Normal Tissues |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prostate—Adca |
NSCLC—Adca |
NSCLC—SCC |
Breast—Adca |
Thyroid—PapAdca |
Colon—Adca |
Lgll—B-CLL |
Lgll—MCL |
Tonsil |
Prostate |
Thyroid |
Pancreas |
Lgl |
Colon |
Lung |
||
| Antigens | n | 1 | 5 | 5 | 10 | 5 | 7 | 5 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
| Nuclear | ||||||||||||||||
| Ki-67 | 5 | 5 | 8 | 6 | 2 | |||||||||||
| p53 | 5 | 5 | 8 | 6 | 1 | |||||||||||
| TTF-1 | 5 | 3 | 5 | 1 | ||||||||||||
| PR A | 1 | 4 | 1 | 1 | ||||||||||||
| ER α | 1 | 1 | 6 | 1 | 1 | 1 | 1 | |||||||||
| CDX-2 | 1 | 4 | 1 | |||||||||||||
| BCL-1 | 5 | 3 | 2 | 1 | 1 | |||||||||||
| Cytoplasmic | ||||||||||||||||
| CD20 | 1 | 5 | 2 | 1 | 1 | |||||||||||
| CK5 | 1 | 5 | 2 | 1 | 1 | 1 | ||||||||||
| CD5 | 2 | 1 | 1 | 3 | 1 | 1 | ||||||||||
| CK7 | 1 | 5 | 2 | 8 | 5 | 2 | 1 | 1 | ||||||||
| Membranous | ||||||||||||||||
| HER-2 | 1 | 2 | 2 | 8 | 2 | 1 | ||||||||||
Abbreviations: Lgll = lymph node; Adca = adenocarcinoma; SCC = squamous cell carcinoma; PapAdca = papillary adenocarcinoma; B-CLL = B chronic lymphatic leukemia; MCL = mantel cell lymphoma.
The table shows the total number of cylinders of each tissue sample (n), within the TMA block. For each antibody the number of cylinders with adequate material for immunohistochemistry evaluation is given.